Seaweed polysaccharides treatment alleviates injury of inflammatory responses and gut barrier in LPS-induced mice
Authors:
- 16 May 2023
- journal article
- research article
- Published by Elsevier in Microbial Pathogenesis
- Vol. 180, 106159
Abstract
No abstract availableKeywords
Funding Information
- State Key Laboratory of Palaeobiology and Stratigraphy
- Nanjing Agricultural University (804131)
This publication has 56 references indexed in Scilit:
- Antibiotic Administration Routes Significantly Influence the Levels of Antibiotic Resistance in Gut MicrobiotaAntimicrobial Agents and Chemotherapy, 2013
- Gut microbiota, epithelial function and derangements in obesityThe Journal of Physiology, 2012
- Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2011
- A core gut microbiome in obese and lean twinsNature, 2008
- Antitumor properties of a sulfated polysaccharide from the red seaweed Champia feldmannii (Diaz‐Pifferer)Journal of Applied Toxicology, 2008
- The effects of seaweed extract inclusion on gut morphology, selected intestinal microbiota, nutrient digestibility, volatile fatty acid concentrations and the immune status of the weaned pigAnimal, 2008
- Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseasesProceedings of the National Academy of Sciences, 2007
- Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant miceProceedings of the National Academy of Sciences, 2006
- Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approachGut, 2005
- The Role of Citrobacter in Clinical Disease of Children: ReviewClinical Infectious Diseases, 1999